Calliditas Therapeutics (CALT) Stock Forecast for 2025, 2026, 2027. Sell or Buy Prediction







How Measurement and Mix Modeling Drive Better Business Decisions

May 22, 2025 How Measurement and Mix Modeling Drive Better Business Decisions

In today’s data-driven business landscape, the ability to accurately measure and optimize marketing efforts has become a critical competitive advantage. As marketing evolves,…
Are you making these mistakes when analyzing candlestick patterns?

May 22, 2025 Are you making these mistakes when analyzing candlestick patterns?

Trading is a very popular endeavor these days, and for good reason, as it is widely accessible and allows individuals to generate additional…
Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency

April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency

What defines a successful crypto expert? The amount of money earned, the number of luxury cars and international real estate? The presence of…
Features of exchanging USDC ERC20 to Bank Transfer

March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer

You can use electronic exchange services if you need to exchange the digital asset USDC ERC20 to Bank Transfer. It is not recommended…
Why Stock Caps Matter When Building a Diversified Portfolio

February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio

Most investors who want to expand their investment options put their money in different asset types and industries across many areas in the…

Calliditas Therapeutics (CALT) Stock Forecast for 2025, 2026, 2027. Sell or Buy?

Updated: May 24, 2025 (19:41)

Sector: Healthcare

The share price of Calliditas Therapeutics AB (publ) (CALT) now

Latest session on the 23rd of May for
Calliditas Therapeutics AB (publ) is negative
Trading Volume: 0
Open: 40 /  High: 40 /  Low: 40
Current value: $40
What analysts predict: $39.25
52-week High/Low: $43 / $21.1
50-Day Moving Average: $39.65 — support level today
200-Day Moving Average: $29.6 — support level today

Are you interested in Calliditas Therapeutics AB (publ) stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Calliditas Therapeutics stock price in 2025, 2026, 2027. How much will one Calliditas Therapeutics share be worth in 2025 - 2027?

When should I take profit in Calliditas Therapeutics stock? When should I record a loss on Calliditas Therapeutics stock? What are analysts' forecasts for Calliditas Therapeutics stock? What is the future of Calliditas Therapeutics stock? We forecast Calliditas Therapeutics stock performance using neural networks based on historical data on Calliditas Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Calliditas Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Calliditas Therapeutics shares. This happens once a day.


Historical and forecast chart of Calliditas Therapeutics stock

The chart below shows the historical price of Calliditas Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Calliditas Therapeutics stock price can be found in the table below.

Long-term forecasts by years.

Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, has focused on identifying, developing and commercializing pharmaceutical products for the treatment of orphan symptoms with an initial focus on kidney and liver diseases. The main candidate for the company’s products is Nefekon, an oral budesonide drug that is an immunosuppressive agent for the treatment of autoimmune IgA renal nephropathy. Calliditas Therapeutics AB (publ) was founded in 2004 and is headquartered in Stockholm, Sweden.

Trending Themes in the Healthcare Sector

Calliditas Therapeutics daily forecast for a month

Date Target Pes. Opt. Vol., %
May 26 40.00 40.00 40.00 0.00
May 27 40.00 40.00 40.00 0.00
May 28 40.00 40.00 40.00 0.00
May 29 40.00 40.00 40.00 0.00
May 30 40.00 40.00 40.00 0.00
May 31 40.00 40.00 40.00 0.00
Jun 01 40.00 40.00 40.00 0.00
Jun 02 40.00 40.00 40.00 0.00
Jun 03 40.00 40.00 40.00 0.00
Jun 04 40.00 40.00 40.00 0.00
Jun 05 40.00 40.00 40.00 0.00
Jun 06 40.00 40.00 40.00 0.00
Jun 07 40.00 40.00 40.00 0.00
Jun 08 40.00 40.00 40.00 0.00
Jun 09 40.00 40.00 40.00 0.00
Jun 10 40.00 40.00 40.00 0.00
Jun 11 40.00 40.00 40.00 0.00
Jun 12 40.00 40.00 40.00 0.00
Jun 13 40.00 40.00 40.00 0.00
Jun 14 40.00 40.00 40.00 0.00
Jun 15 40.00 40.00 40.00 0.00
Jun 16 40.00 40.00 40.00 0.00
Jun 17 40.00 40.00 40.00 0.00
Jun 18 40.00 40.00 40.00 0.00
Jun 19 40.00 40.00 40.00 0.00
Jun 20 40.00 40.00 40.00 0.00
Jun 21 40.00 40.00 40.00 0.00
Jun 22 40.00 40.00 40.00 0.00
Jun 23 40.00 40.00 40.00 0.00
Jun 24 40.00 40.00 40.00 0.00

Calliditas Therapeutics Daily Price Targets


Calliditas Therapeutics Stock Forecast 05-26-2025.

Forecast target price for 05-26-2025: $40.00.
Negative dynamics for Calliditas Therapeutics shares will prevail with possible volatility of 0.000%.
Pessimistic target level: 40.00
Optimistic target level: 40.00

Calliditas Therapeutics Stock Forecast 05-27-2025.

Forecast target price for 05-27-2025: $40.00.
Negative dynamics for Calliditas Therapeutics shares will prevail with possible volatility of 0.000%.
Pessimistic target level: 40.00
Optimistic target level: 40.00

Calliditas Therapeutics Stock Forecast 05-28-2025.

Forecast target price for 05-28-2025: $40.00.
Negative dynamics for Calliditas Therapeutics shares will prevail with possible volatility of 0.000%.
Pessimistic target level: 40.00
Optimistic target level: 40.00

Calliditas Therapeutics Stock Forecast 05-29-2025.

Forecast target price for 05-29-2025: $40.00.
Negative dynamics for Calliditas Therapeutics shares will prevail with possible volatility of 0.000%.
Pessimistic target level: 40.00
Optimistic target level: 40.00

Calliditas Therapeutics Stock Forecast 05-30-2025.

Forecast target price for 05-30-2025: $40.00.
Negative dynamics for Calliditas Therapeutics shares will prevail with possible volatility of 0.000%.
Pessimistic target level: 40.00
Optimistic target level: 40.00

Calliditas Therapeutics Stock Forecast 05-31-2025.

Forecast target price for 05-31-2025: $40.00.
Negative dynamics for Calliditas Therapeutics shares will prevail with possible volatility of 0.000%.
Pessimistic target level: 40.00
Optimistic target level: 40.00

CALT (CALT) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jun. 46.12 39.85 51.29 22.32
Jul. 61.33 46.32 66.34 30.18
Aug. 63.62 49.56 68.60 27.75
Sep. 45.24 38.16 54.31 29.74
Oct. 50.62 41.15 58.02 29.07
Nov. 56.47 50.14 60.50 17.14
Dec. 75.29 64.54 89.37 27.78

Calliditas Therapeutics forecast for this year


Calliditas Therapeutics Stock Prediction for Jun 2025

An uptrend is forecast for this month with an optimal target price of $46.1201. Pessimistic: $39.85. Optimistic: $51.29


Calliditas Therapeutics Stock Prediction for Jul 2025

An uptrend is forecast for this month with an optimal target price of $61.3305. Pessimistic: $46.32. Optimistic: $66.34


Calliditas Therapeutics Stock Prediction for Aug 2025

An uptrend is forecast for this month with an optimal target price of $63.6243. Pessimistic: $49.56. Optimistic: $68.60


Calliditas Therapeutics Stock Prediction for Sep 2025

An downtrend is forecast for this month with an optimal target price of $45.2369. Pessimistic: $38.16. Optimistic: $54.31


Calliditas Therapeutics Stock Prediction for Oct 2025

An uptrend is forecast for this month with an optimal target price of $50.6201. Pessimistic: $41.15. Optimistic: $58.02


Calliditas Therapeutics Stock Prediction for Nov 2025

An uptrend is forecast for this month with an optimal target price of $56.4717. Pessimistic: $50.14. Optimistic: $60.50


Calliditas Therapeutics Stock Prediction for Dec 2025

An uptrend is forecast for this month with an optimal target price of $75.2881. Pessimistic: $64.54. Optimistic: $89.37



Calliditas Therapeutics (CALT) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 82.20 76.05 97.29 21.83
Feb 93.94 84.36 100.65 16.18
Mar 105.12 85.82 130.85 34.42
Apr 96.54 71.26 110.98 35.79
May 105.07 92.57 121.15 23.59
Jun 98.29 84.25 123.35 31.70
Jul 93.27 77.42 104.06 25.60
Aug 82.49 65.94 97.36 32.27
Sep 82.49 64.26 90.90 29.31
Oct 97.36 82.46 106.95 22.90
Nov 126.15 91.84 136.88 32.90
Dec 158.75 130.14 174.94 25.61

Calliditas Therapeutics (CALT) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 142.56 122.20 157.10 22.21
Feb 152.25 120.16 163.64 26.57
Mar 130.51 110.54 164.23 32.69
Apr 89.24 78.62 105.02 25.14
May 110.79 84.80 126.61 33.02
Jun 93.84 76.61 102.77 25.46
Jul 86.50 80.62 95.03 15.16
Aug 83.85 76.44 95.25 19.75
Sep 68.74 59.16 86.50 31.61
Oct 61.26 46.06 71.88 35.93
Nov 70.84 54.71 87.70 37.63
Dec 55.67 40.53 63.24 35.92

Calliditas Therapeutics information and performance

Calliditas Therapeutics Address

KUNGSBRON 1, C8, STOCKHOLM, SE

Market Capitalization: 1 096 595 000 $

Market capitalization of the Calliditas Therapeutics AB (publ) is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of CALT shares in the company outstanding by the market price of one share.

EBITDA: -365 368 992 $

EBITDA of Calliditas Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -1.76

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 1.078
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 14.64

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 7.09

Enterprise Value (EV) /Revenue

EV To EBITDA: -0.804

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 27016700

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

FAQ (Frequently Asked Questions about Calliditas Therapeutics Stock)

Should I Buy Calliditas Therapeutics Shares in 2025 year?

The maximum forecasted share price for next year is $158.75, which is $118.75 higher than the current stock price. By investing in Calliditas Therapeutics shares today for a one-year period, you could achieve a profit of 296.88%. With an investment horizon of up to two years, the target share price is $152.25. resulting in a profit of 280.63% ($112.25 per share).

Does Calliditas Therapeutics pay dividends?

No, it does not

Which economic sector do Calliditas Therapeutics's shares belong to?

Calliditas Therapeutics's shares belong to the "Healthcare" sector of economic.

Which other securities belong to the same sector as Calliditas Therapeutics's shares?

You can view all the stocks that are part of the same sector as Calliditas Therapeutics's shares in the Healthcare section.


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.